The Unseen Force Driving Oncology's Bottom Line and Innovation

MINNEAPOLIS, MN – June 23, 2026 – When Conexiant announced that registration was open for its 14th annual JADPRO Live conference, it may have looked like a routine industry notice. The event, scheduled for October in Minneapolis, gathers the nation’s oncology advanced practitioners (APs)—a group including nurse practitioners, physician associates, and pharmacists. But beneath the surface of this educational gathering lies a critical story about the shifting economics and operational realities of modern cancer care. In an industry grappling with a projected shortage of oncologists and increasingly complex treatments, the role of the AP is no longer just supportive; it is foundational to both clinical outcomes and the financial viability of healthcare systems.

A Workforce Under Pressure, A Market in Flux

The theme of this year's conference, "APs at the Heart of Cancer Care," is more than a slogan; it's a statement of market reality. The reliance on APs has exploded. Data shows the percentage of oncology practices employing APs jumped from 52% to 81% in just three years. This isn't a matter of preference but of necessity. An aging population, a growing number of cancer survivors requiring long-term management, and a looming physician deficit have created a perfect storm that APs are uniquely positioned to navigate.

This growing workforce, estimated at over 7,000 strong, is a powerhouse of direct patient care, dedicating up to 85% of their time to clinical activities. They are prescribing complex medications, managing treatment side effects, counseling patients, and increasingly, running their own clinics. For hospital administrators and practice managers, investing in the training and integration of APs is a direct play for efficiency and scale. They extend the reach of a supervising oncologist, allowing practices to see more patients and manage more complex cases, directly impacting revenue and the ability to compete.

"Across the country, APs are driving innovation, leading change, and providing high-quality, evidence-based care to patients," said Amber Koehler, MPAS, PA-C, of Mayo Clinic and the 2026 Conference Chair. Her statement underscores a crucial point: this is not about filling gaps with less-qualified personnel. Studies consistently show no significant difference in adherence to quality care recommendations between physicians and APs, and patient satisfaction remains high. The business case is clear: a well-supported AP workforce is a strategic asset for delivering cost-effective, high-quality oncology care.

The Curriculum as a Business Indicator

To understand where the oncology market is heading, one need only look at the JADPRO Live 2026 agenda. The 25+ accredited sessions go far beyond basic training. With topics like "Bispecific Antibodies vs. CAR T-Cell Therapy," the conference is arming APs with the knowledge to manage some of the most advanced—and expensive—therapies on the market. These are not just clinical decisions; they are multi-million dollar economic choices for healthcare institutions.

Furthermore, sessions like "Building and Scaling an APP-Led Clinic" signal a fundamental shift in practice management. APs are being trained not just as clinicians, but as business unit leaders. This evolution is critical. As value-based care models become more prevalent, the ability of APs to manage patient populations efficiently, reduce hospitalizations, and navigate complex survivorship care becomes a core driver of an organization's financial health. The conference's tracks on multimodal therapy, including radiation and surgical oncology, further cement the AP's role as a central coordinator in a patient's entire treatment journey, a position that holds immense power over care pathways and costs.

The Strategic Backbone: Conexiant and APSHO's Long Game

JADPRO Live is not an isolated event. It is the flagship initiative of a carefully constructed ecosystem built by Conexiant and the Advanced Practitioner Society for Hematology and Oncology (APSHO). Conexiant, a B2B media and information services company, has consolidated a portfolio of healthcare education brands to create a platform reaching over 2.6 million professionals. Its strategy is to become the essential information hub for specialized medical fields, and oncology is a prime vertical. By controlling the dominant educational and networking event for oncology APs, Conexiant positions itself at the center of the industry's professional development and, by extension, influences purchasing and treatment decisions.

APSHO, the 6,000-member professional society behind the conference, provides the clinical credibility and community. Founded in 2014, its mission is to formalize the role of the AP in oncology. Through advocacy, standard-setting, and leadership development, APSHO is solidifying the profession's legitimacy. Its recent recognition in a President's Cancer Panel Report and its vocal stance on federal workforce proposals demonstrate an organization moving beyond education into active policy-shaping. Together, Conexiant provides the business platform and reach, while APSHO provides the professional mandate, creating a powerful engine for elevating the role of the AP across the entire healthcare landscape.

A Strategic Hub in the Heartland

The choice of Minneapolis for the 2026 conference is no accident. The city is a nexus of world-class cancer care and research. It is a stone's throw from the renowned Mayo Clinic Comprehensive Cancer Center and home to the University of Minnesota's Masonic Cancer Center, both NCI-Designated institutions. By bringing the nation's APs to this hub, JADPRO Live facilitates a powerful cross-pollination of ideas between community practitioners and academic leaders.

This location strategy serves a dual purpose. It provides attendees with access to a top-tier medical environment and reinforces the message that cutting-edge care is not confined to the coasts. For a workforce that is critically important in bridging care gaps in rural and underserved areas, holding the premier conference in the nation's heartland is a symbolic and practical masterstroke. It underscores that the innovation discussed in the conference halls is meant to be disseminated throughout the country, impacting patient care from major metropolitan hospitals to regional community clinics.